🇺🇸 FDA
Patent

US 9261507

Anti CEACAM1 antibodies and methods of using same

granted A61KA61K2039/505A61K35/17

Quick answer

US patent 9261507 (Anti CEACAM1 antibodies and methods of using same) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Grant date
Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505, A61K35/17, A61K39/39558, A61K45/06